if SAVA gets cut in half, goes to 25, which is not gonna happen unless the entire market cracks, and I do not see that happeneing, it would have a 1 billion market cap, and 250 million, as i recall, in cash.
I think sava missed a tremendous opp to buy avxl, when sava's share price was 130. They could have used some of the shares of course, and then diluted. Say SAVA share wouuld have been cut in half, so the s/p is 60 to 65 bucks, but now SAVA would own anavex. ....and it would have had far more protection from the shorts with 2 technologies, and avxl is advancing other drugs, plus SAVA has its diagnostic product.
both companies would merge, be far stronger because I would not be surprised if Big Pharma has a serious role in this ongoing short attack. The CNS markets are so massive, big pharma will do anything to keep out the small creative effective companies, and with a corrupted fDA, who knows about the future, and the FDA is indeed corrupt. All of the federal agencies are rogue and corrupt now, and FDA just proved it with the biogen decision. How corrupt is the question, let's hope for the best. fed workers are all corrupted and make war on the citizens these days, just like in CCP or the old soviets.
fAll that said, buying SAVA in the mid 30s has many merits, one of which is that it can only fall another 35 points.
AI
Market Data 
Markets 
